Pain Relief by Intra-Peritoneal Ropivacaine During Gynecological Laparoscopy

Pain Relief by Continuous Intra-Peritoneal Nebulization of Ropivacaine During Gynecological Laparoscopic Surgery

In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecological laparoscopic surgery.

Inclusion Criteria:

• Elective gynecologic laparoscopic surgery including unilateral or bilateral salpingo-oopherectomy or ovarian cystectomy.
• The patient is not participating in other medical study at present or in the last 30 days.
• The patient signed on an informed consent.
• Age 18 years and above.
• ASA (American Society of Anesthesiologists) physical status grade 1- 2.

Exclusion Criteria:

• Allergy to Ropivacaine, other local anesthetics or other medications listed in the protocol.
• The patient is participating in other medical experiment at present or in the last 30 days.
• Acute Pelvic Inflammatory Disease.
• Coumadin or Aspirin treatment.
• ASA physical status grade 3-4.
• Age < 18 years.
• Significant arrythmias
• Analgesic treatment for chronic pain